Search
Back

Semaglutide

CAS 910463-68-2
Semaglutide

General Information

Semaglutide (sold under brand names Ozempic® (Injection) and Rybelsus® (Oral) is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in the therapy of type 2 diabetes.


About the API

Technology Peptide
Therapeutic category Diabetes
Available formulations Injectables
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.